Literature DB >> 14707108

Periportal fibrosis in human Schistosoma mansoni infection is associated with low IL-10, low IFN-gamma, high TNF-alpha, or low RANTES, depending on age and gender.

Mark Booth1, Joseph K Mwatha, Sarah Joseph, Frances M Jones, Hilda Kadzo, Edmund Ireri, Frances Kazibwe, Jovanice Kemijumbi, Curtis Kariuki, Gachuhi Kimani, John H Ouma, Narcis B Kabatereine, Birgitte J Vennervald, David W Dunne.   

Abstract

Schistosoma mansoni infection is highly endemic in parts of Uganda, and periportal fibrosis is common in communities along the shore of Lake Albert. In this study, we have identified cellular immune responses associated with fibrosis. A cohort of 199 individuals aged 6-50, resident in the village for at least 10 years or since birth, were examined for evidence of periportal fibrosis by ultrasound using the Niamey protocol. Whole-blood samples were assayed for levels of nine cellular immune molecules (IL-3, IL-4, IL-5, IL-10, IL-13, TNF-alpha, IFN-gamma, IL-1beta, and RANTES) in the absence of in vitro Ag stimulation, and after stimulation with egg and worm Ags. A lack of Ag specificity allowed the number of variables in the analysis to be reduced by factor analysis. The resulting factor scores were then entered into a risk analysis using a classification tree algorithm. Children, adult males, and adult females had different factors associated with fibrosis. Most cases of fibrosis in children (eight of nine) were associated with low (<47th percentile) IL-10 factor scores. Adult females at lowest risk had relatively high IFN-gamma factor scores (>83rd percentile), whereas those at highest risk had a combination of intermediate (32nd to 83rd percentile) IFN-gamma and relatively high (>60th percentile) TNF-alpha factor scores. Adult males at lowest risk of fibrosis had moderate TNF-alpha factor scores (55th to 82nd percentile), and a high risk was associated with either high TNF-alpha factor scores (>82nd percentile), or intermediate TNF-alpha combined with low RANTES factor scores (<58th percentile). These results demonstrate that periportal fibrosis is associated with cytokine production profiles that vary with both age and gender.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14707108     DOI: 10.4049/jimmunol.172.2.1295

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  66 in total

Review 1.  Fibrotic disease and the T(H)1/T(H)2 paradigm.

Authors:  Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

2.  The chemokine, CCL3, and its receptor, CCR1, mediate thoracic radiation-induced pulmonary fibrosis.

Authors:  Xuebin Yang; William Walton; Donald N Cook; Xiaoyang Hua; Stephen Tilley; Christopher A Haskell; Richard Horuk; A William Blackstock; Suzanne L Kirby
Journal:  Am J Respir Cell Mol Biol       Date:  2010-09-24       Impact factor: 6.914

3.  T-helper-2 cytokine responses to Sj97 predict resistance to reinfection with Schistosoma japonicum.

Authors:  Tjalling Leenstra; Luz P Acosta; Hai-Wei Wu; Gretchen C Langdon; Julie S Solomon; Daria L Manalo; Li Su; Mario Jiz; Blanca Jarilla; Archie O Pablo; Stephen T McGarvey; Remigio M Olveda; Jennifer F Friedman; Jonathan D Kurtis
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

Review 4.  The WHO ultrasonography protocol for assessing hepatic morbidity due to Schistosoma mansoni. Acceptance and evolution over 12 years.

Authors:  Tarik el Scheich; Martha C Holtfreter; Hendrik Ekamp; Daman D Singh; Rodrigo Mota; Christoph Hatz; Joachim Richter
Journal:  Parasitol Res       Date:  2014-09-27       Impact factor: 2.289

5.  Schistosoma mansoni PCR+ -infected individuals in the Sudan present elevated systemic levels of chemokines when compared to uninfected and egg+ cohorts.

Authors:  K Arndts; T E M Elfaki; N Jelden; M Ritter; A Wiszniewsky; G Katawa; I A Goreish; M E Y A Atti El Mekki; M J Doenhoff; A Hoerauf; L E Layland
Journal:  Clin Exp Immunol       Date:  2019-03-19       Impact factor: 4.330

6.  Nuclear factor-kappaB1 (p50) limits the inflammatory and fibrogenic responses to chronic injury.

Authors:  Fiona Oakley; Jelena Mann; Sarah Nailard; David E Smart; Narendra Mungalsingh; Christothea Constandinou; Shakir Ali; Susan J Wilson; Harry Millward-Sadler; John P Iredale; Derek A Mann
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

7.  Allograft inflammatory factor-1 alleviates liver disease of BALB/c mice infected with Schistosoma japonicum.

Authors:  Qiong-Rong Chen; Fei Guan; Shu-Mei Song; Jian-Kang Jin; Dan-Sheng Lei; Chun-Mei Chen; Jia-Hui Lei; Zheng-Wang Chen; An-Ou Niu
Journal:  Parasitol Res       Date:  2014-05-10       Impact factor: 2.289

8.  Hepatic stellate cells and parasite-induced liver fibrosis.

Authors:  Barrie Anthony; Jeremy T Allen; Yuesheng S Li; Donald P McManus
Journal:  Parasit Vectors       Date:  2010-07-21       Impact factor: 3.876

9.  Schistosoma japonicum egg antigen up-regulates fibrogenesis and inhibits proliferation in primary hepatic stellate cells in a concentration-dependent manner.

Authors:  Ping Liu; Mi Wang; Xiao-Dan Lu; Shu-Juan Zhang; Wang-Xian Tang
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

10.  sTNFR-II and sICAM-1 are associated with acute disease and hepatic inflammation in schistosomiasis japonica.

Authors:  Magda K Ellis; Yuesheng Li; Xunya Hou; Honggen Chen; Donald P McManus
Journal:  Int J Parasitol       Date:  2007-10-12       Impact factor: 3.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.